REGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugsREGULATORYRFK Jr.: 14 peptides returning to Category 1 — FDA advisory committee July 2026UPDATESemaglutide and tirzepatide compounding ended — shortage resolved Feb/May 2025REGULATORYBPC-157, TB-500, thymosin alpha-1, CJC-1295, ipamorelin: expected Category 1 reclassification pendingFDAFDA advisory committee meetings scheduled: late July 2026RESEARCHTranslational Health Research Into Vascular and Neurocognitive Effects of Weight Loss [NCT07592546]RESEARCHA Master Protocol of Multiple Agents in Adults With Metabolic Dysfunction-Associated Steatotic Liver Disease (SYNERGY-Outcomes) [NCT07165028]RESEARCHTirzepatide in the Treatment of Endometrial Cancer [NCT07605247]RESEARCHA Study of Tirzepatide (LY3298176) in Participants With Type 2 Diabetes During Ramadan [NCT06635057]RESEARCHA Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide [NCT06897475]RESEARCHA Phase 2 Study of Vosoritide in Children With Idiopathic Short Stature [NCT06382155]RESEARCHMetabolic Effects of Angiotensin-(1-7) [NCT02646475]RESEARCHMulti-Site Trial of Tirzepatide for Smoking Cessation [NCT07602699]RESEARCHEvaluation of Tirzepatide as an Adjunct to Buprenorphine for the Treatment of Opioid Use Disorder [NCT06651177]NEWSOorja, run by Acceleron veterans, launches to make new fibrosis drugs

For research purposes only. Full disclaimer →

All Contacts
Joe Rogan
Influencer

Joe Rogan

About

Joseph James Rogan Jr. (born August 11, 1967) is an American podcaster, UFC color commentator, comedian, actor, and former television host. He hosts The Joe Rogan Experience, which is one of the most popular podcasts in the world and has been the most streamed podcast on Spotify since 2020. Rogan was born in Newark, New Jersey, and began his career in comedy in 1988 in the Boston area. After relocating to Los Angeles in 1994, he signed an exclusive developmental deal with Disney and appeared as an actor on several television shows, including Hardball and NewsRadio. In 1997, he started working for the UFC as an interviewer and color commentator. He released his first comedy special, I'm Gonna Be Dead Someday..., in 2000 and hosted the game show Fear Factor from 2001 to 2006. After leaving Fear Factor, Rogan focused on his stand-up career and hosted more comedy specials. He launched The Joe Rogan Experience in 2009; by 2015, it was one of the most popular podcasts in the world, regularly receiving millions of plays per episode. Spotify obtained exclusive distribution rights to The Joe Rogan Experience in 2020 for $200 million. Rogan's audience has since grown significantly, and in 2024, he renewed his deal with Spotify for an estimated $250 million, but will no longer be exclusive to them. Rogan has voiced support for same-sex marriage, recreational drug legalization, universal health care, universal basic income, gun rights, and free speech, while opposing cancel culture and military adventurism. Rogan has been criticized for promoting conspiracy theories, COVID-19 misinformation, transphobia and for hosting guests who spread misinformation and pseudoscience. Having previously endorsed Ron Paul in 2012 and Bernie Sanders in 2020, Rogan supported Donald Trump in 2024. He later criticized some of Trump's policies, while still making public appearances with him.

Videos